NCT05298761View on ClinicalTrials.gov

Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 30, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

June 1, 2024

Conditions

Hemodynamic Stability

Interventions

DRUG

Lignocaine

Inj lignocain and inj nalbuphine given to two groups of participants and effects of both drugs

Trial Locations (1)

092

Dr.amna, Rahim Yar Khan

All Listed Sponsors

lead

Sheikh Zayed Medical College

OTHER_GOV

NCT05298761 - Efficacy of I/v Nalbuphine v/s Iv Lignocain in Attanuation of Pressor Responseduring Laryngeoscopy and Intubation in Middle Age Patient Planned for Thyroid Surgery | Biotech Hunter | Biotech Hunter